• August 2016

Top-Tier Global Private Equity Firm Engages HEC to Assist Medical Device Portfolio Company with Sales Force Effectiveness Training Project 

• September 2016

HEC Assists UK OTC Supplement Company to Accelerate Growth and Raise Seed Funding to Execute New Commercial Strategy

• October 2016

HEC Helps London Based Sports Fitness Start-up Raise Funds, Develop Branding and Optimize the Customer Experience

• January 2017

U.S. Specialty Pharma Company Engages HEC to Assist in Raising Series A Funding to Support Phase IIb Trial in Treatment Resistant Depression

• March 2017

Growth Phase Pharma Services Company Retains HEC to Secure New Business with EU CMOs & CPOs

• August 2017

 HEC Designs Global Launch Strategy for Australian HealthTech Start-up  

• September 2017

Leading Emerging Markets Private Equity Fund Engages HEC to Build HealthTech Venture Capabilities 

• June 2018

Managing Director Jason C. Foster Joins Board of Directors of HEC Portfolio Companies GripAble (UK) and Auxita (AUS) as Non-Executive Director  

• April - August 2019

HEC Assists in Closing Over £12M in Seed Funding for 4 Portfolio Companies

• August 2019

Managing Director Jason C. Foster Joins Board of Directors of HEC Portfolio Companies Salve Technologies (UK), Credentially (UK) and Ori Biotech (UK and US)

• April 2020

 HEC Assisting Portfolio Companies in Organisational Realignments Due to COVID-19 and Series A Fundraising

• July 2020

 HEC Invests Alongside Mediclinic and Steyn Group in Swiss Healthcare Procurement Platform hystrix Medical AG

 • August 2020

Ori Biotech raises $30M Series A round